Avecho Biotechnology Ltd AVEFF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.10
- Market Cap
- $9.51 Mil
- Volume/Avg
- 320,000 / 320,000
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.44
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology TPM, for the pharmaceutical, skincare and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 34
- Website
- https://www.avecho.com.au
Valuation
|
Metric
|
AVEFF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.15 |
Price/Sales | 1.44 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
AVEFF
|
|---|---|
Quick Ratio | 2.06 |
Current Ratio | 2.22 |
Interest Coverage | — |
Quick Ratio
AVEFF
Profitability
|
Metric
|
AVEFF
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
AVEFF
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Xdlgwhrnd | Pywh | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Jdbhztwxn | Zgtfm | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Bmdbllz | Ddkds | $97.8 Bil | |
MRNA
| Moderna Inc | Ctknmkrl | Nrsn | $41.3 Bil | |
ARGX
| argenx SE ADR | Xnswblfr | Zkqk | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Xndgnysbl | Gqd | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Fknxrywk | Rbnqsr | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Jbzpcnc | Mcbwz | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Kzgpvhjnb | Qypcnsv | $12.5 Bil | |
INCY
| Incyte Corp | Jhffpyrjg | Lyjtdy | $11.6 Bil |